Jingling Su
Impact in
- Immunology top 10%
- IL-33, ST2, and ILC Pathways
- Psoriasis: Treatment and Pathogenesis
- Immune Cell Function and Interaction
- Gastroenterology top 10%
Papers in
- Genetics 8
- Inflammatory Bowel Disease 8
-
- Psoriasis: Treatment and Pathogenesis 4
- Immunodeficiency and Autoimmune Disorders 1
- Co-authors
- Zhanju Liu (5 shared papers)Praveen Kumar Yadav (3 shared papers)Fei Ke (1 shared paper)Junshan Wang (1 shared paper)Ping‐Chang Yang (2 shared papers)Xingpeng Wang (1 shared paper)Ruijin Wu (1 shared paper)Changqin Liu (1 shared paper)
- Journals
- Scientific Reports (2 papers)Medicine (1 paper)Frontiers in Cellular and Infection Microbiology (1 paper)BMC Gastroenterology (1 paper)The Journal of Nutritional Biochemistry (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Jingling Su
16 papers receiving 522 citations
Peers
Comparison fields: 5 of 61
- Immunology 228
- Gastroenterology 29
- Genetics 151
- Genetics 41
- Pathology and Forensic Medicine 50
Countries citing papers authored by Jingling Su
This map shows the geographic impact of Jingling Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingling Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingling Su more than expected).
Fields of papers citing papers by Jingling Su
This network shows the impact of papers produced by Jingling Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingling Su. The network helps show where Jingling Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Jingling Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 125 | |
| 2 | 2011 | 122 | |
| 3 | 2013 | 90 | |
| 4 | 2011 | 48 | |
| 5 | Interleukin-25 primed mesenchymal stem cells achieve better therapeutic effects on dextran sulfate sodium-induced colitis via inhibiting Th17 immune response and inducing T regulatory cell phenotype. | 2017 | 32 |
| 6 | 2023 | 31 | |
| 7 | 2019 | 26 | |
| 8 | 2023 | 19 | |
| 9 | 2020 | 11 | |
| 10 | Interleukin-25 enhances the capacity of mesenchymal stem cells to induce intestinal epithelial cell regeneration. | 2017 | 10 |
| 11 | 2022 | 3 | |
| 12 | 2019 | 3 | |
| 13 | 2022 | 3 | |
| 14 | 2025 | 2 | |
| 15 | 2024 | 2 | |
| 16 | 2022 | 2 | |
| 17 | 2025 | 0 |
About Jingling Su
Jingling Su is a scholar working on Genetics, Immunology, Infectious Diseases, Molecular Biology and Gastroenterology, having authored 17 papers that have together received 529 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (8 papers), Psoriasis: Treatment and Pathogenesis (4 papers), Gastrointestinal motility and disorders (2 papers), Gut microbiota and health (2 papers), Clostridium difficile and Clostridium perfringens research (2 papers), Immunodeficiency and Autoimmune Disorders (1 paper), Therapeutic Uses of Natural Elements (1 paper) and Pancreatitis Pathology and Treatment (1 paper). The work is most often cited by research in Immunology (228 citations), Gastroenterology (29 citations), Genetics (151 citations), Genetics (41 citations) and Pathology and Forensic Medicine (50 citations). Jingling Su has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Zhanju Liu, Praveen Kumar Yadav, Fei Ke, Junshan Wang, Ping‐Chang Yang, Xingpeng Wang, Ruijin Wu, Changqin Liu, Tengfei Chen and Xiaorong Xu. Their work appears in journals such as Scientific Reports, Medicine, Frontiers in Cellular and Infection Microbiology, BMC Gastroenterology and The Journal of Nutritional Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.